Healthcare provider profile · identity verified

John Wehrle, MD

Family Practice · MACEDON, NY · NPI 1568576593

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	803	217
Omeprazole	Omeprazole	458	127
Lisinopril	Lisinopril	446	120
Amlodipine Besylate	Amlodipine Besylate	404	99
Levothyroxine Sodium	Levothyroxine Sodium	358	84
Gabapentin	Gabapentin	354	87
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	284	72
Albuterol Sulfate Hfa	Albuterol Sulfate	267	73
Hydrochlorothiazide	Hydrochlorothiazide	247	65
Simvastatin	Simvastatin	247	65
Fluticasone Propionate	Fluticasone Propionate	199	56
Citalopram Hbr	Citalopram Hydrobromide	196	51
Eliquis	Apixaban	194	32
Pantoprazole Sodium	Pantoprazole Sodium	189	47
Losartan Potassium	Losartan Potassium	182	52
Metformin Hcl	Metformin Hcl	182	54
Furosemide	Furosemide	166	42
Metoprolol Tartrate	Metoprolol Tartrate	163	39
Meloxicam	Meloxicam	157	46
Metoprolol Succinate	Metoprolol Succinate	154	42
Trazodone Hcl	Trazodone Hcl	149	34
Tamsulosin Hcl	Tamsulosin Hcl	137	39
Glimepiride	Glimepiride	129	36
Alendronate Sodium	Alendronate Sodium	122	33
Clopidogrel	Clopidogrel Bisulfate	115	26
Atenolol	Atenolol	113	32
Famotidine	Famotidine	111	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	103	20
Rosuvastatin Calcium	Rosuvastatin Calcium	100	30
Tramadol Hcl	Tramadol Hcl	97	32
Montelukast Sodium	Montelukast Sodium	93	23
Clonazepam	Clonazepam	87	16
Potassium Chloride	Potassium Chloride	87	17
Allopurinol	Allopurinol	82	22
Metformin Hcl Er	Metformin Hcl	82	19
Prednisone	Prednisone	81	56
Pravastatin Sodium	Pravastatin Sodium	74	23
Pregabalin	Pregabalin	73	13
Duloxetine Hcl	Duloxetine Hcl	70	16
Triamcinolone Acetonide	Triamcinolone Acetonide	69	38
Celecoxib	Celecoxib	68	13
Venlafaxine Hcl Er	Venlafaxine Hcl	65	13
Doxycycline Monohydrate	Doxycycline Monohydrate	62	50
Jardiance	Empagliflozin	60	16
Paroxetine Hcl	Paroxetine Hcl	59	15
Naproxen	Naproxen	58	16
Spironolactone	Spironolactone	58	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	14
Lorazepam	Lorazepam	53	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	24
Combivent Respimat	Ipratropium/Albuterol Sulfate	49	suppressed
Warfarin Sodium	Warfarin Sodium	49	16
Aripiprazole	Aripiprazole	47	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	46	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	37
Carvedilol	Carvedilol	44	suppressed
Sertraline Hcl	Sertraline Hcl	44	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	44	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	42	suppressed
Buspirone Hcl	Buspirone Hcl	42	suppressed
Meclizine Hcl	Meclizine Hcl	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	36	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	34	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	32	suppressed
Cephalexin	Cephalexin	32	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	12
Digoxin	Digoxin	28	suppressed
Azithromycin	Azithromycin	27	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	27	suppressed
Ibuprofen	Ibuprofen	26	12
Nabumetone	Nabumetone	26	11
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Amoxicillin	Amoxicillin	25	23
Farxiga	Dapagliflozin Propanediol	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Irbesartan	Irbesartan	24	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Torsemide	Torsemide	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Ozempic	Semaglutide	20	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	15
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Felodipine Er	Felodipine	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Brilinta	Ticagrelor	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Nystatin	Nystatin	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Ramipril	Ramipril	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Pen Needle	Pen Needle, Diabetic	11	suppressed
Rybelsus	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error